Impact of comorbidity and relative dose intensity on outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP

被引:0
|
作者
Masakazu Yamamoto
Ikuko Suzuki
Kouji Saitou
Riko Tsumanuma
Shuhei Okuyama
Hiroaki Kumagai
Eijiro Omoto
Shinji Satoh
Katsushi Tajima
机构
[1] Yamagata University School of Medicine,Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology
[2] Okitama Public General Hospital,Department of Hematology
[3] Okitama Public General Hospital,Working Group of Chemotherapy of Hematology
[4] Yamagata Prefectural Central Hospital,Department of Hematology
关键词
Comorbidity; Relative dose intensity; Diffuse large B-cell lymphoma; Elderly;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2995 / 3002
页数:7
相关论文
共 50 条
  • [41] Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma
    Morrison, Vicki A.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (10) : 1651 - 1658
  • [42] Impact of Occult Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Arima, Hiroshi
    Maruoka, Hayato
    Nasu, Koji
    Funayama, Yuki
    Takeda, June
    Yamauchi, Nobuhiko
    Aoki, Kazunari
    Kato, Aiko
    Ono, Yuichiro
    Nagano, Seiji
    Takiuchi, Yoko
    Tabata, Sumie
    Matsushita, Akiko
    Imai, Yukihiro
    Takahashi, Takayuki
    Ishikawa, Takayuki
    [J]. BLOOD, 2011, 118 (21) : 685 - 686
  • [43] Influence of dose reduction of vincristine in R-CHOP on outcomes of diffuse large B cell lymphoma
    Utsu, Yoshikazu
    Takaishi, Koji
    Inagaki, Shunichirou
    Arai, Hironori
    Yuasa, Hiromi
    Masuda, Shinichi
    Matsuura, Yasuhiro
    Aotsuka, Nobuyuki
    Wakita, Hisashi
    [J]. ANNALS OF HEMATOLOGY, 2016, 95 (01) : 41 - 47
  • [44] Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge
    Lavacchi, Daniele
    Landini, Ida
    Perrone, Gabriele
    Roviello, Giandomenico
    Mini, Enrico
    Nobili, Stefania
    [J]. PHARMACOLOGY & THERAPEUTICS, 2022, 229
  • [45] Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP
    A. Bosly
    D. Bron
    A. Van Hoof
    R. De Bock
    Z. Berneman
    A. Ferrant
    L. Kaufman
    M. Dauwe
    G. Verhoef
    [J]. Annals of Hematology, 2008, 87 : 277 - 283
  • [46] Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma
    Choi, Soyeon
    Lee, Yoo Jin
    Choi, Yunsuk
    Kim, Misung
    Kim, Hyun-Jung
    Kim, Ji Eun
    Oh, Sukjoong
    Chae, Seoung Wan
    Cha, Hee Jeong
    Jo, Jae-Cheol
    [J]. JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2022, 56 (05) : 281 - 288
  • [47] Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP
    Bosly, A.
    Bron, D.
    Van Hoof, A.
    De Bock, R.
    Berneman, Z.
    Ferrant, A.
    Kaufman, L.
    Dauwe, M.
    Verhoef, G.
    [J]. ANNALS OF HEMATOLOGY, 2008, 87 (04) : 277 - 283
  • [48] R-CHOP compared with CHOP in patients with diffuse large B-cell lymphoma (DLCL): Russian experience
    Poddubnaya, I.
    Osmanov, E.
    Babicheva, L.
    Tumyan, G.
    Sorokin, E.
    Stefanov, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Clinical impact of immunohistochemical subtyping in patients with de novo diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy
    Melachroinou, M.
    Plakoula, E.
    Lampropoulou, P.
    Sirinian, C.
    Symeonidis, A.
    [J]. VIRCHOWS ARCHIV, 2013, 463 (02) : 215 - 215
  • [50] Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age
    Eyre, T. A.
    Martinez-Calle, N.
    Hildyard, C.
    Eyre, D. W.
    Plaschkes, H.
    Griffith, J.
    Wolf, J.
    Fields, P.
    Gunawan, A.
    Oliver, R.
    Djebbari, F.
    Booth, S.
    McMillan, A.
    Fox, C. P.
    Bishton, M. J.
    Collins, G. P.
    Hatton, C. S. R.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2019, 285 (06) : 681 - 692